Transgenic overexpression of GTP-cyclohydrolase-1, the enzyme that is responsible for de novo synthesis of BH4, is associated with improvement of cardiovascular complications in animal models of atherosclerosis [83], hypertension [84], and diabetes [85] by normalizing the coupling state and function of eNOS [86]. The gene discussed is NOS3; the disease is hypertensive disorder.